|
|
||||||||
Department of Immunology, Duke University Medical Center, Durham, NC 27710
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The CD4 and CD8 coreceptors play a critical role in the outcome of the TCR-peptide/MHC interaction. Binding of the coreceptor to the appropriate MHC molecule stabilizes the TCR recognition complex, primarily by decreasing the rate of dissociation (4), and enhances signaling through the engaged TCR via recruitment of the protein tyrosine kinase, p56lck (5). The trimer of TCR, coreceptor, and MHC molecule is thought to provide the optimal signal to the engaged T cell during thymic selection and peripheral activation (6, 7).
Alterations in coreceptor expression levels have been shown to significantly disrupt the selection of transgenic TCRs. Decreased coreceptor expression renders certain TCRs unable to meet the avidity threshold for positive selection, while forced overexpression raises the avidity of interaction above the threshold where negative selection occurs (8, 9, 10, 11, 12, 13). Coreceptor-mediated enhancement of TCR signaling has also been shown to play a critical role in thymic selection (14). Transgenic mice expressing tail-less coreceptors that are unable to participate in lck recruitment have been generated (15, 16, 17). These mice are dramatically impaired in their ability to select the corresponding T cell lineage. Interestingly, CD4 T cell development in the tailless CD4 mice is restored as the tailless transgene is increasingly overexpressed (15), arguing that a high degree of surface adhesive interactions can compensate for the lack of signaling through the coreceptor.
While coreceptor-mediated enhancement of TCR adhesion and signaling
clearly modulates selection of the mature TCR repertoire, coreceptor
engagement does not appear to be absolutely required for development of
T helper cell function. Helper cell activity is apparent in CD4
knockout mice, as evidenced by the generation of an effective Th1
response upon challenge with Leishmania (18); this activity
is attributed to an expanded population of double negative
TCR-
ß+ T cells (19, 20, 21). However, CD4 null mice were
subsequently shown to be unable to mount an effective Th2 response to
infection with Nippostrongylus brasiliensis (22). Further
studies have confirmed a generalized defect in Th2-mediated responses
in CD4 knockout mice, suggesting that CD4 may actually be quite
important in the development of effector function (22, 23).
Alternatively, these findings might be explained if the absence of CD4
results in the selection of a restricted repertoire of Th cell
specificities.
Our studies were undertaken to address the role of the CD4 coreceptor and its interaction with the MHC class II molecule during thymic selection and T cell development. The absence of a CD4+ T cell compartment in class II-deficient (C2D) mice provides evidence that class II molecules are necessary for selection of CD4+ T cells (24, 25). However, the effect of the class II-TCR interaction vs the class II-CD4 coreceptor interaction cannot be specifically addressed in these animals. To specifically examine the role of the class II-CD4 interaction, we have generated mice expressing class II molecules mutated in the CD4 binding domain (26). Class II knockout (I-Ab ß-chain-deficient) mice were reconstituted with either a wild-type I-Ab ß-chain transgene (Aß WT)4, or an I-Ab ß-chain transgene encoding the EA137/VA142 double mutation in the CD4 binding site in the ß2 domain (Aß MUT). Functional abrogation of the class II-CD4 interaction was demonstrated by increased TCR and CD4 levels on double positive thymocytes from the class II MUT mice (26). Importantly, whereas binding of the class II molecule to the CD4 coreceptor is disrupted by the mutation, peptide presentation to the TCR remains intact. Another critical feature of this model is that selection of all class II-restricted T cells occurs on class II molecules that are unable to functionally engage CD4. This is in contrast with other transgenic systems expressing MHC class I molecules mutated in the CD8 binding domain, which examine the selection only of a single TCR specificity (27, 28).
Abrogation of the CD4-class II interaction is predicted to inhibit selection of CD4+ T cells by decreasing the avidity of interaction between the immature thymocyte and the selecting ligand. As predicted, in vivo disruption of the class II-CD4 interaction significantly impaired selection into the CD4 compartment (26). The number of CD4+ T cells was reduced by one-half in the thymus and by two-thirds in the periphery of the class II MUT mice. Furthermore, selection of CD4+ T cells expressing the class II-restricted AND TCR transgene (29) was completely eliminated on the class II MUT background, arguing that the CD4-class II interaction is essential for the selection of at least certain TCR specificities.
In this report, we describe the phenotype of the CD4+ T cells that are successfully selected in the class II MUT mice. CD4+ T cells that develop under these conditions are predicted to be a CD4-independent subset of the preselection repertoire, bearing TCRs of sufficient affinity for the class II ligand to undergo selection in the absence of a productive class II-CD4 interaction. We show that CD4+ T cells from class II MUT mice, unlike the residual population of CD4+ T cells in C2D mice, can respond to T-dependent Ags and support Ig isotype switching. Furthermore, we show that CD4+ T cells from the class II MUT mice are indeed CD4 independent with respect to their peripheral activation requirements. Surprisingly, we find that CD4+ T cells from the class II MUT mice respond equally well when stimulated with either wild-type or mutant class II molecules. This unexpected result suggests that CD4+ T cells from the class II MUT mice, having been selected in the absence of a productive class II-CD4 interaction, fail to functionally engage CD4 even when subsequently provided with a wild-type class II ligand.
| Materials and Methods |
|---|
|
|
|---|
Wild-type Aß transgenic and mutant Aß (EA137/VA142) transgenic mice were generated as described (26). Mice were housed in a specific pathogen-free barrier facility (Duke University, Durham, NC).
Flow cytometry
Single cell suspensions of lymphocytes (12 x
106 cells) were incubated for 30 min on ice in a final
volume of 50 µl with Fc block (50 µg/ml; PharMingen, San Diego,
CA), and the indicated combinations of Abs directly conjugated to FITC
or phycoerythrin (PE). Anti-CD4 (H129.19), CD8
(53-6.7), and CD3
(29B) were from Life Technologies (Grand Island, NY). Analyses were
performed on a FACScan flow cytometer (Becton Dickinson, Mountainview,
CA) using CELLQUEST software.
Immunizations
For the proliferation assays, 8- to 10-wk-old male mice were injected i.p. with 100 µg of keyhole limpet hemocyanin (KLH; Sigma, St. Louis, MO) or at the base of the tail with 100 µg (50 µg per side) OVA (Sigma). Antigens were solubilized in PBS (1 µg/µl) and emulsified 1:1 with CFA (Sigma) before injection. For the isotype-switching experiments, 8-wk-old mice were injected i.p. with 100 µg of 2,4 dinitrophenyl-conjugated KLH (DNP-KLH; Calbiochem-Novabiochem, La Jolla, CA) emulsified in CFA and boosted 21 days later.
Preparation of lymphocytes
Mesenteric lymph nodes from KLH-immunized mice were harvested 58 days postimmunization. Single cell suspensions were prepared by mincing of lymph nodes with forceps. Cell suspensions were washed with PBS, resuspended in RPMI-10 media (RPMI 1640 without sodium bicarbonate, 10% newborn calf serum, 20 mM HEPES) at 40 x 106 cells/ml and incubated on anti-IgM-coated plates for 30 min at room temperature. Anti-IgM-coated plates were prepared by incubating tissue culture dishes with 100 µg/ml anti-IgM (µ-chain) Ab (Cappel, ICN Pharmaceuticals, Aurora, OH) overnight at 4°C. After passage over anti-IgM-coated plates, cells were collected, washed, and resuspended at 106 cells/ml in complete media (RPMI 1640, 10% FCS, 2 mM glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, 10-5 M 2-ME). In some experiments anti-IgM-treated cells were depleted of either CD4+ or CD8+ T cells by incubation with anti-CD4 or anti-CD8 Ab-coated magnetic beads (Dynabeads M-450; Dynal, Oslo, Norway). Cell suspensions were adjusted to 1040 x 106 cells/ml in RPMI-10 media, and rocked for 30 min at 4°C at a bead-to-target ratio of 3:1 before placement against a magnet for 2 min. The supernatant was collected, and the T-depleted populations were washed, resuspended at 106 cells/ml in complete media, and used as responders in proliferation assays. FACS analysis of lymphocytes after T cell depletion revealed 99% elimination of the depleted CD4+ or CD8+ subset. OVA-specific lymphocytes were harvested from inguinal and periaortic lymph nodes 89 days post base-of-tail immunization. Single cell suspensions were generated, and cells were washed and resuspended at 106 cells/ml in complete media for use in proliferation assays.
Preparation of anti-CD4 Fabs
GK1.5 ascites (obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health: L3T4 monoclonal Ab (GK1.5), operated by Ogden BioSevices Corporation, Rockville, MD) was passed over a T-gel purification column (Pierce, Rockford, IL). The purified Ig was concentrated in a Centricon 100 filter (Amicon, Beverly MA) and dialyzed overnight at 4°C against dialysis buffer (10 mM EDTA, 20 mM phosphate, pH 7.0) in a 3-ml Slide-A-Lyzer pouch (Pierce). Fab fragments were generated by incubation of the dialyzed Ig with immobilized papain (Pierce) as per manufacturers instructions. The papain-treated Ig was then incubated with protein G (Life Technologies) for 45 min at 37°C to remove any undigested Ab. The remaining Fab fragments were dialyzed against media, quantified by determination of OD, and filter sterilized before use in proliferation assays.
Cell proliferation assays
Proliferation assays were performed in 96-well U-bottom plates
with 105 responders and 105 stimulators per
well in a total volume of 200 µl. To prepare APCs, splenocytes from
nonimmunized mice were cultured overnight in 10 ml of complete media at
4 x 106 cells/ml in the presence of the indicated
concentration (0100 µg/ml) of KLH or OVA258276
peptide (IINFEKLTEWTSSNVMEER, Peptide Synthesis Facility, Department of
Microbiology, University of North Carolina, Chapel Hill, NC). The
pulsed stimulators were then washed, irradiated (3000 rad), and
resuspended in complete media at 106 cells/ml for plating.
Anti-CD4 Fabs (GK1.5; 6 µg/ml), anti-CD8
Abs (53-6.7; 30
µg/ml, PharMingen), and anti-MHC II Abs (25-9-17; 30 µg/ml,
PharMingen) were included as indicated. Plates were pulsed at 78 h
with 1.0 µCi [3H]thymidine in 25 µl media/well and
harvested at 96 h with a PhD cell harvester. Filters were
suspended in Betafluor (National Diagnostics, Atlanta, GA), and
[3H]thymidine incorporation was measured on a Packard
1900CA Tri-Carb Liquid Scintillation Analyzer.
Isotype-specific Ab ELISA
Sera from DNP-KLH-immunized mice were collected by retroorbital bleed at days 0, 7, 14, 21, and 28 and stored at -20°C until Ab titers were measured. Relative Ab levels from individual serum samples were determined using ELISA plates (Costar, Cambridge, MA) coated overnight at 4°C with DNP-conjugated BSA (5 µg/ml; Calbiochem-Novabiochem). Plates were washed three times in Tris-buffered saline and blocked for one h at 37°C in a solution containing 2% BSA and 1% gelatin. Following three washes, test sera (diluted 1/1,000) were added in duplicate and incubated at room temperature for 2 h. Plates were washed three times and incubated for 1 h at room temperature with alkaline phosphatase-conjugated goat anti-mouse isotype-specific Abs (2 µg/ml; Southern Biotechnology Associates, Birmingham, AL). The plates were washed five times, and alkaline phosphatase activity was detected following addition of p-nitrophenyl phosphate (Sigma). The OD was measured at a wavelength of 405 nm, and the mean OD from duplicate wells was compared between groups of animals.
| Results |
|---|
|
|
|---|
C2D mice have virtually no conventional class II-restricted
CD4+ T cells (24, 25). The residual CD4+ T
cells are largely NK1.1+ T cells restricted by the
nonclassical CD1 molecule (30). These mice do not mount responses to
T-dependent Ags and cannot support Ig isotype switching (24, 25). In
the EA137/VA142 Aß MUT mice, the number of CD4+ T cells
is reduced by one-half in the thymus and by two-thirds in the periphery
(Fig. 1
and Table I
). Moreover, nearly one-third of the
peripheral CD4+ T cells are NK1.1+ (26). Of
note, this does not represent an increase in the absolute number of
CD4+ NK1.1+ T cells in the Aß MUT mice;
rather, their proportion is high because the number of conventional
class II-restricted CD4+ T cells is so dramatically
reduced. However, given that the Aß MUT mice develop so few
CD4+ T cells and that a significant proportion belong to
the NK1.1+ subset, it was important to determine whether
Aß MUT mice were capable of mounting class II-restricted
proliferative and helper responses.
|
|
|
To determine whether the KLH-specific T cells from the Aß MUT mice
were responding independently of CD4 engagement, the proliferation
assays were repeated in the presence of anti-CD4-blocking Fab
fragments. Fab fragments were used since whole Ab to CD4 has been shown
to induce negative signaling and would thus inhibit a response (33). As
expected, inclusion of anti-CD4 Fabs significantly inhibited
(>66%) the proliferation of the KLH-specific lymphocytes from the
class II WT mice. However, the response of lymphocytes from the class
II MUT mice was not susceptible to inhibition by the anti-CD4 Ab
when stimulated by either WT or MUT APCs (Fig. 2
E).
Thus, in contrast to the residual CD4+ T cells found in C2D mice, CD4+ T cells from the EA137/VA142 Aß MUT mice are functional as measured by proliferation to the T-dependent Ags, KLH and OVA. Significantly, the KLH-specific CD4+ T cells derived from the class II MUT mice are CD4 independent in their peripheral activation requirements; they respond to Aß MUT APCs and are not susceptible to inhibition by anti-CD4 Fabs. These results suggest that CD4+ T cells from the class II MUT mice, having been selected in the absence of a productive class II-CD4 interaction, are subsequently able to undergo peripheral activation in a coreceptor-independent manner.
Of note, the time course of the KLH-specific response (but not of the OVA-specific response) was reproducibly delayed by several days in the Aß MUT vs Aß WT mice. In the class II MUT mice, the maximal KLH-specific response was detected in lymph nodes harvested 78 days postimmunization, whereas in the class II WT mice, the maximal response occurred at days 45 postimmunization and was virtually undetectable by day 8 (data not shown). This may reflect a decrease in the precursor frequency of KLH-specific CD4+ T cells in the class II MUT mice and is not surprising, inasmuch as a restriction in the peripheral repertoire would be a predicted consequence of thymic selection in the absence of a functional class II-CD4 interaction.
CD4+ T cells are responsible for the majority of the KLH-specific response in Aß MUT mice
To confirm that the KLH-specific response observed in the class II
MUT mice was mounted by the CD4+ T cells, proliferation
assays were repeated with purified T cell populations. Mesenteric lymph
node cells were depleted of B cells by passage over anti-IgM coated
plates and further purified by incubation with either anti-CD4- or
anti-CD8-coated magnetic beads. FACS analysis revealed that the
purified populations were less than 1% positive for the depleted T
cell subset (data not shown). The Ag-specific response was clearly
present in the purified CD4+ T cell compartment of both the
class II WT and MUT responders (Fig. 3
).
Of note, CD4+ T cells from Aß WT mice required 10-fold
more Ag to proliferate when stimulated with MUT APCs than when
stimulated with WT APCs (Fig. 3
A). However, as observed in
the experiments with whole T cell populations, purified
CD4+ T cells from the Aß MUT mice proliferated equally
well in response to either WT or MUT APCs (Fig. 3
B). The
inclusion of anti-I-Ab mAb inhibited the response of
purified CD4+ T cells from both the class II WT and MUT
mice, confirming that the responding cells were indeed MHC class
II-restricted CD4+ T cells (Fig. 3
C).
|
Interestingly, purified CD8+ T cells from the class II
MUT mice also gave rise to a detectable KLH-specific response (Fig. 3
B). Although minor compared with the CD4+ T
cell response, this finding was reproducible in subsequent experiments
(Fig. 4
A). The inclusion of
anti-CD8 Abs inhibited the response observed in the
CD8+ compartment (Fig. 4
B). This response was
also inhibited by anti-class II Abs, demonstrating the presence of
class II-restricted Ag-specific CD8+ T cells in the class
II MUT mice (Fig. 4
C).
|
Inasmuch as CD4+ T cells present in Aß MUT mice are
capable of mounting an Ag-specific response to the T-dependent Ag KLH,
we tested their ability to support a fully differentiated Ig response.
Mice were immunized with DNP-KLH at day 0, boosted at day 21, and bled
at days 0, 7, 14, and 28. Serum was stored at -20°C for Ab isotype
titering by anti-DNP ELISA. The response of Aß MUT mice was
compared with C2D mice as negative controls and Aß WT and
nontransgenic C57BL/6 mice as positive controls. DNP-specific Ab titers
were determined for IgM, IgG1, IgG2a, IgG2b, IgG3, and IgA (Fig. 5
). As previously shown, no Ig isotypes
were detected following immunization of C2D mice, apart from a moderate
IgM response (24, 25). In contrast, immunization of Aß MUT, Aß WT,
and C57BL/6 mice resulted in the detectable presence of each Ab isotype
examined throughout the time course of the experiment. Differences in
Ab titers between the Aß MUT and Aß WT controls were not
statistically significant.
|
| Discussion |
|---|
|
|
|---|
Interestingly, whereas the time course of the maximal KLH response was delayed in the Aß MUT vs the Aß WT mice, the time course of the OVA response was very similar (days 911 for both). This finding is consistent with the idea that the class II MUT mice possess T cells with the relevant OVA specificity, such that the time course of the response is not delayed, but that the delay in the KLH response reflects a narrowing in the repertoire of KLH-specific T cells. This is not unlikely, given that KLH is a far more complex Ag than OVA, so that the KLH response of the Aß MUT mice as compared with the response of the Aß WT mice could consist of different TCR specificities or be directed at different epitopes of the KLH protein.
An important predicted consequence of having been selected in an environment devoid of functional class II-CD4 interactions is that CD4+ T cells in the class II MUT mice will be CD4 independent in their peripheral activation requirements. The experiments presented in this report support this hypothesis. KLH-specific T cells from Aß MUT mice proliferated vigorously when stimulated with MUT APCs. Furthermore, the response was not inhibited by the inclusion of anti-CD4 Fab fragments, demonstrating that the T cells from the class II MUT mice are responding in a coreceptor-independent manner. Similarly, TCR transgenic CD8+ T cells, in mice expressing class I molecules unable to bind CD8, displayed CD8-independent lysis of target cells (35).
Intriguingly, the response of T cells from the Aß MUT mice was not augmented when stimulated with APCs expressing WT class II proteins. These results are in striking contrast to those obtained with CTLs derived from mice expressing class I molecules with suboptimal affinity for CD8 (35). In these studies, the magnitude of the lytic response was significantly increased when the CD8+ T cells were provided with target cells bearing class I molecules that could productively engage CD8. The results in the Aß MUT mice were also surprising inasmuch as the introduction of wild-type CD4 into a CD4- variant of an Ag-specific hybridoma has been shown to enhance IL-2 production (36). Similarly, Ag-specific CD4- (or CD8-) hybridomas were shown to respond at lower peptide doses when CD4 (or CD8) was provided (17, 36, 37, 38, 39).
Our observations in the Aß MUT mice might not be surprising if the T
cell were already being maximally stimulated, despite the absence of
coreceptor engagement. However, if this were the case, the presence of
effective coreceptor engagement would be expected to have an effect at
lower Ag doses, such that a shift in the dose-response curve would be
observed in the presence of WT APCs. The absence of such a shift
suggests that there may be an intrinsic defect in CD4 recruitment or
signaling pathways in the CD4+ T cells from the class II
MUT mice. Viola et al. have shown that triggered TCRs and coreceptors
are coordinately down-modulated, even when the MHC-coreceptor
interaction does not occur (40). This coordinated down-regulation is
thought to be due to the recruitment of CD4-associated lck by
CD3
/ZAP-70. It will be critical to determine whether this
recruitment of CD4 still occurs in lymphocytes from the Aß MUT mice
or whether CD4 is sequestered from the TCR complex such that it can no
longer be recruited, even in the presence of a WT class II ligand.
Alternatively, our observations may be more simply explained if the TCRs expressed on CD4+ T cells in the Aß MUT mice are of higher intrinsic affinity for MHC/peptide complexes. A model for how higher affinity TCR-MHC/peptide interactions may translate mechanistically into CD4-independent T cells was proposed by Davis and colleagues (39), based on a "sequential engagement" model wherein CD4 acts to stabilize preformed clusters of TCR-MHC/peptide complexes (41, 42). In this model, CD4 recruitment occurs following TCR-MHC/peptide engagement and only for those complexes that can engage the TCR for at least 12 s at 25°C, which is in the range of measured affinities seen with typical CD4-dependent T cells interacting with an agonist peptide/MHC complex (43). Recruited CD4 may then serve to stabilize the complex and allow the generation of a full activation signal. TCR-MHC/peptide interactions, which are intrinsically more stable will last longer, and, although they too may recruit CD4, the recruited CD4 may be of little consequence for the generation of a complete activation signal. Thus, in the case of higher affinity or "CD4-independent" T cells, CD4 recruitment may not appear to contribute to the response, qualitatively or quantitatively. The phenotype of the CD4+ T cells selected in the Aß MUT mice is consistent with this hypothesis.
The presence of a class II-restricted Ag-specific response in the CD8+ T cell compartment is another notable outcome of selection in the Aß MUT background. Selection of these class II-restricted CD8+ T cells can be potentially accounted for by several mechanisms. In the Aß MUT mice, selection of class II-restricted TCRs must be occurring independently of CD4 engagement. Therefore, any T cell bearing a TCR with high affinity for MHC II could potentially undergo positive selection, regardless of which coreceptor it maintains. The increased TCR levels on double-positive thymocytes in the Aß MUT mice (26) might also facilitate selection of TCRs that would normally require coreceptor-mediated interactions. Alternatively, TCR-independent MHC class I-CD8 interactions might facilitate selection of class II-restricted CD8+ T cells in the Aß MUT mice. Kirbirg et al. have demonstrated that, in mice transgenic for a class II-restricted TCR, both CD4+CD8- and CD4-CD8+ T cells expressing the transgenic TCR develop, but that full maturation of the CD8+ transgenic T cells requires expression of class I as well as class II MHC molecules (44). Likewise, Matachek et al. have demonstrated that, in CD4 knockout mice, selection of the class II-restricted AND TCR transgene into the CD8 compartment requires both class I and class II molecules (45). As we have previously reported, selection of the AND TCR transgene into the CD4 compartment is completely eliminated in the Aß MUT mice (26). However, a small population of AND TCR+ CD8+ T cells are present in the periphery of AND/Aß MUT mice (16% vs 5% in AND/Aß WT mice, data not shown). Furthermore, this population is reduced to background (5%) if Aß MUT mice expressing the AND TCR transgene are crossed onto a ß2-microglobulin-/- background (manuscript in preparation). These data argue that selection of the class II-restricted CD8+ T cells in the Aß MUT mice may indeed utilize TCR-independent class I-CD8 interactions.
While we favor the hypothesis that the CD4+ T cells present in the Aß MUT mice have been selected based on expression of high affinity TCRs, TCR-independent class I-CD8 interactions could be facilitating selection of both CD4+ and CD8+ T cells. To determine whether TCR-independent class I-CD8 interactions are required for selection of CD4+ T cells in the Aß MUT mice, we have crossed the Aß MUT transgenic line onto an MHC knockout background, such that the only MHC molecules available for mediating selection are the EA137/VA142 MUT class II molecules. As expected, selection of CD8+ T cells was completely eliminated in the absence of class I molecules (data not shown). However, no decrease in the efficiency of CD4+ T cell selection was observed, arguing that TCR-independent class I-CD8 interactions are not required for selection of CD4+ T cells in the Aß MUT mice.
We have demonstrated that the CD4+ T cells present in the Aß MUT mice are functional T helper cells and are coreceptor-independent in their peripheral activation requirements. Ongoing experiments with Ag-specific hybridomas derived from the Aß MUT mice are designed to more specifically examine the issues of TCR affinity and alterations in peripheral T cell repertoire. Recent evidence suggests that class II-CD4 interactions are important in Th2 vs Th1 subset differentiation (22, 23, 46, 47). Future experiments will utilize the Aß MUT mice to examine Th development in the absence of productive class II-CD4 engagement.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Current address: Department of Immunology, St. Jude Childrens Research Hospital, 570 St. Jude Place, Memphis, TN 38105. ![]()
3 Address correspondence and reprint requests to Dr. Carolyn Doyle, Department of Immunology, Duke University Medical Center, Box 3010 Jones Building, Room 104, Durham, NC 27710. E-mail address: ![]()
4 Abbreviations used in this paper: Aß WT, wild-type I-Ab ß-chain transgene; Aß MUT, I-Ab ß-chain transgene encoding the EA137/VA142 double mutation in the CD4 binding site in the ß2 domain; C2D, class II-deficient; PE, phycoerythrin; KLH, keyhole limpet hemocyanin; MLN, mesenteric lymph node. ![]()
Received for publication June 26, 1998. Accepted for publication August 21, 1998.
| References |
|---|
|
|
|---|
/ß T cell receptor-expressing thymocytes in transgenic mice. J. Exp. Med. 175:1013.
3 domain of MHC I molecules. Nature 352:718.[Medline]
/CD3-CD4 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases. Immunol. Today 15:225.[Medline]
and interleukin-2 production concomitantly with enhanced interleukin-4. CIin. Immunol. 73:245.
This article has been cited by other articles:
![]() |
Q. Wang, L. Malherbe, D. Zhang, K. Zingler, N. Glaichenhaus, and N. Killeen CD4 Promotes Breadth in the TCR Repertoire J. Immunol., October 15, 2001; 167(8): 4311 - 4320. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |